Has Rebecca Gillingham received payments from drug or device companies?

Yes. Drug and device makers reported $9,620 in general payments to Rebecca Gillingham across 399 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rebecca Gillingham did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rebecca Gillingham come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rebecca Gillingham

Psychiatric/Mental Health · Saratoga Springs, NYNPI 1386134260

Payments from drug & device makers

$9,620in general payments, 2019–2025

Across 399 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
AbbVie$2K
Axsome Therapeutics, Inc.$968
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$654
Teva Pharmaceuticals USA, Inc.$527
Otsuka America Pharmaceutical, Inc.$486
plus $3K from 16 others

What the payments were for

Food & beverage$9,54599%
Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	62	$2,095
AbbVie	79	$1,778
Axsome Therapeutics, Inc.	51	$968
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	23	$654
Teva Pharmaceuticals USA, Inc.	19	$527
Otsuka America Pharmaceutical, Inc.	11	$486
Alkermes, Inc.	16	$485
Vanda Pharmaceuticals Inc.	29	$467
Corium, LLC	28	$409
Neurocrine Biosciences, Inc.	11	$301
Lundbeck LLC	15	$282
Supernus Pharmaceuticals, Inc.	7	$265
Idorsia Pharmaceuticals US Inc	11	$262
Takeda Pharmaceuticals U.S.A., Inc.	9	$157
Novo Nordisk	7	$119
Bausch Health US, LLC	5	$82
Sunovion Pharmaceuticals Inc.	6	$77
E.r. Squibb & Sons, L.L.C.	3	$76
Ironshore Pharmaceuticals Inc.	3	$68
Almatica Pharma LLC	2	$31
OWP Pharmaceuticals, Inc.	1	$19
Avanir Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,620 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Quetiapine Fumarate	13	$111
Lorazepam	11	$78

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Saratoga Springs

Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K
Kayanna JonasFar Rockaway$93K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →